Carnegie Investment Counsel Has $1.50 Million Holdings in Intuitive Surgical, Inc. $ISRG

Carnegie Investment Counsel increased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 92.7% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 3,253 shares of the medical equipment provider’s stock after buying an additional 1,565 shares during the period. Carnegie Investment Counsel’s holdings in Intuitive Surgical were worth $1,500,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also bought and sold shares of ISRG. Norges Bank acquired a new stake in Intuitive Surgical during the 4th quarter worth about $2,856,987,000. J. Stern & Co. LLP lifted its stake in shares of Intuitive Surgical by 18,504.6% in the 4th quarter. J. Stern & Co. LLP now owns 2,127,248 shares of the medical equipment provider’s stock valued at $1,204,788,000 after purchasing an additional 2,115,814 shares during the period. Northwestern Mutual Wealth Management Co. lifted its stake in shares of Intuitive Surgical by 1,043.3% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 1,342,121 shares of the medical equipment provider’s stock valued at $760,124,000 after purchasing an additional 1,224,734 shares during the period. Polen Capital Management LLC bought a new stake in shares of Intuitive Surgical during the 4th quarter valued at about $477,225,000. Finally, Assenagon Asset Management S.A. boosted its position in shares of Intuitive Surgical by 106.6% during the 4th quarter. Assenagon Asset Management S.A. now owns 1,533,771 shares of the medical equipment provider’s stock valued at $868,667,000 after purchasing an additional 791,516 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Key Intuitive Surgical News

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: TD Cowen kept a Buy rating on Intuitive Surgical while trimming its price target from $585 to $520, signaling that the analyst still sees upside despite a more conservative valuation view. TD Cowen lowers ISRG price target to $520
• Positive Sentiment: Royal Bank of Canada also lowered its target, from $650 to $600, but maintained an Outperform rating, reinforcing a constructive outlook ahead of earnings. RBC lowers ISRG price target to $600
• Positive Sentiment: Multiple articles highlighted Intuitive Surgical as a leading robotics and automation name for the second half of 2026, with investors viewing the company as a beneficiary of AI-enabled surgical robotics growth. Zacks robotics stock list mentions ISRG
• Positive Sentiment: Bearish recent performance has made the stock look more attractive to some analysts, with coverage pieces arguing ISRG could offer roughly 35% upside before earnings if management confirms solid demand and margins. 247WallSt ISRG upside article
• Neutral Sentiment: Intuitive Surgical is expected to report second-quarter EPS of about $2.50 on revenue near $2.82 billion after the close on July 16, with investors likely waiting for results and guidance before making a bigger move. ISRG earnings preview
• Negative Sentiment: The main negative takeaway is that both TD Cowen and RBC reduced their price targets, which suggests analysts are becoming a bit more cautious on valuation even while staying bullish overall.

Insider Buying and Selling

In related news, SVP Iman Jeddi sold 5,625 shares of the firm’s stock in a transaction dated Monday, June 1st. The shares were sold at an average price of $420.55, for a total value of $2,365,593.75. Following the transaction, the senior vice president owned 6,463 shares of the company’s stock, valued at approximately $2,718,014.65. This trade represents a 46.53% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Gary Loeb sold 400 shares of Intuitive Surgical stock in a transaction dated Wednesday, June 10th. The shares were sold at an average price of $424.14, for a total value of $169,656.00. Following the transaction, the executive vice president owned 5,720 shares of the company’s stock, valued at $2,426,080.80. This trade represents a 6.54% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 7,169 shares of company stock worth $3,059,135 in the last quarter. Insiders own 0.60% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages have weighed in on ISRG. Barclays set a $651.00 target price on Intuitive Surgical and gave the stock an “overweight” rating in a report on Thursday, April 23rd. Citigroup restated a “buy” rating on shares of Intuitive Surgical in a report on Wednesday, July 8th. Truist Financial reduced their price objective on shares of Intuitive Surgical from $650.00 to $580.00 and set a “buy” rating for the company in a research report on Wednesday, April 15th. Wall Street Zen upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Saturday, June 13th. Finally, Leerink Partners dropped their target price on shares of Intuitive Surgical from $622.00 to $573.00 and set an “outperform” rating on the stock in a research report on Wednesday, April 22nd. One research analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $562.12.

Intuitive Surgical Trading Up 0.1%

Shares of ISRG stock opened at $407.12 on Tuesday. The firm has a market capitalization of $144.19 billion, a PE ratio of 49.35, a price-to-earnings-growth ratio of 3.31 and a beta of 1.46. The firm has a fifty day simple moving average of $421.09 and a two-hundred day simple moving average of $472.71. Intuitive Surgical, Inc. has a 12 month low of $396.68 and a 12 month high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share for the quarter, beating analysts’ consensus estimates of $2.08 by $0.42. The firm had revenue of $2.77 billion for the quarter, compared to analyst estimates of $2.62 billion. Intuitive Surgical had a net margin of 28.15% and a return on equity of 15.98%. The business’s quarterly revenue was up 23.0% compared to the same quarter last year. During the same period last year, the firm earned $1.81 earnings per share. On average, equities analysts predict that Intuitive Surgical, Inc. will post 8.57 earnings per share for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.